# Nutriband Inc. (NTRB)

Source: https://www.quantisnow.com/company/NTRB
Generated: 2026-11-19T21:56:37.031Z

- Ticker: NTRB
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Industrial Specialties
- SEC CIK: 0001676047
- Website: nutriband.com

## About

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida.

## Latest NTRB news and filings

- 2026-11-17 12:00 UTC [Nutriband Announces USPTO Notice of Allowance for Commercial Brand Name Trademarks for Its Abuse-Deterrent Fentanyl Transdermal System](https://www.quantisnow.com/insight/nutriband-announces-uspto-notice-of-allowance-for-commercial-brand-name-6795579)
- 2026-10-13 12:00 UTC [Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274](https://www.quantisnow.com/insight/nutriband-inc-announces-exercise-of-warrants-at-643-for-gross-6744198)
- 2026-10-08 11:00 UTC [Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology](https://www.quantisnow.com/insight/nutriband-files-new-patent-application-to-strengthen-intellectual-property-protection-6740976)
- 2026-10-01 20:05 UTC [Public Offering] [Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders](https://www.quantisnow.com/insight/nutriband-marks-five-years-on-nasdaq-ceo-letter-to-shareholders-6732338)
- 2026-09-30 20:12 UTC [SEC Form 25-NSE filed by Nutriband Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-nutriband-inc-6730651)
- 2026-09-25 12:00 UTC [Leadership Update] [Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate  Robert J. O'Neill to Advisory Board](https://www.quantisnow.com/insight/nutriband-appoints-decorated-navy-seal-and-veterans-health-advocate-robert-6726019)
- 2026-09-23 21:27 UTC [SEC Form 8-K] [Nutriband Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nutriband-inc-filed-sec-form-8-k-regulation-fd-disclosure-financial-6724485)
- 2026-09-22 12:00 UTC [Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing](https://www.quantisnow.com/insight/nutriband-confirms-warrants-will-expire-september-30-without-extension-or-6722399)
- 2026-09-09 13:20 UTC [Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit](https://www.quantisnow.com/insight/nutriband-ceo-gareth-sheridan-to-attend-the-nasdaq-life-sciences-6709624)
- 2026-09-08 13:00 UTC [Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch](https://www.quantisnow.com/insight/nutriband-receives-uspto-notice-of-publication-of-commercial-brand-name-6707803)
- 2026-08-13 11:00 UTC [Conference Announcement] [Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight](https://www.quantisnow.com/insight/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-6679146)
- 2026-06-22 12:02 UTC [SEC Form 8-K] [Nutriband Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nutriband-inc-filed-sec-form-8-k-entry-into-a-material-6610097)
- 2026-05-18 20:44 UTC [SEC Form 10-K] [Amendment: SEC Form 10-K/A filed by Nutriband Inc.](https://www.quantisnow.com/insight/amendment-sec-form-10-ka-filed-by-nutriband-inc-6560673)
- 2026-05-15 11:00 UTC [Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference](https://www.quantisnow.com/insight/nutriband-inc-to-showcase-expanding-ai-wellness-product-portfolio-and-6555534)
- 2026-04-29 21:13 UTC [SEC Form 10-K] [SEC Form 10-K filed by Nutriband Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-nutriband-inc-6521960)
- 2026-04-22 11:00 UTC [Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast](https://www.quantisnow.com/insight/nutriband-ceo-gareth-sheridan-discusses-the-us-fentanyl-crisis-and-6509328)
- 2026-04-07 19:43 UTC [SEC Form 8-K] [Nutriband Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nutriband-inc-filed-sec-form-8-k-regulation-fd-disclosure-financial-6491076)
- 2026-03-30 20:05 UTC [Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch](https://www.quantisnow.com/insight/nutriband-selects-commercial-brand-name-for-its-abuse-deterrent-fentanyl-6476515)
- 2026-03-18 11:00 UTC [Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica](https://www.quantisnow.com/insight/nutriband-ai-kinesiology-tapes-approved-for-distribution-and-sale-in-6454749)
- 2026-02-17 12:00 UTC [Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica](https://www.quantisnow.com/insight/nutriband-signs-exclusive-distribution-agreement-with-innomedica-for-aversa-fentanyl-6394074)
- 2026-02-13 21:58 UTC [SEC Form 8-K] [Nutriband Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nutriband-inc-filed-sec-form-8-k-regulation-fd-disclosure-financial-6393004)
- 2026-02-03 18:44 UTC [SEC Form 8-K] [Nutriband Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nutriband-inc-filed-sec-form-8-k-submission-of-matters-to-6371890)
- 2026-01-30 12:00 UTC [Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points](https://www.quantisnow.com/insight/nutriband-inc-provides-summary-of-annual-shareholder-meeting-key-discussion-6367007)
- 2025-12-31 12:00 UTC [Dividends] [Nutriband CEO Publishes Letter to Shareholders](https://www.quantisnow.com/insight/nutriband-ceo-publishes-letter-to-shareholders-6330494)
- 2025-12-30 21:28 UTC [SEC Form 8-K] [Nutriband Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nutriband-inc-filed-sec-form-8-k-regulation-fd-disclosure-financial-6330033)
- 2025-12-29 14:00 UTC [Public Offering] [Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio](https://www.quantisnow.com/insight/nutriband-inc-signs-agreement-to-sell-majority-stake-of-subsidiary-6328050)
- 2025-12-19 16:01 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Nutriband Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-nutriband-inc-6323365)
- 2025-12-18 13:00 UTC [Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration](https://www.quantisnow.com/insight/nutriband-inc-signs-letter-of-intent-with-qvanta-group-of-6321304)
- 2025-12-18 12:00 UTC [Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction](https://www.quantisnow.com/insight/nutriband-differentiates-prescription-fentanyl-from-illicit-fentanyl-in-response-to-6321171)
- 2025-11-25 22:12 UTC [SEC Form 5] [SEC Form 5 filed by Sheridan Gareth](https://www.quantisnow.com/insight/sec-form-5-filed-by-sheridan-gareth-6293997)
- 2025-10-28 16:00 UTC [SEC Form 8-K] [Nutriband Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nutriband-inc-filed-sec-form-8-k-regulation-fd-disclosure-financial-6247506)
- 2025-10-28 15:05 UTC [REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch](https://www.quantisnow.com/insight/repeat-nutriband-announces-successful-meeting-completed-with-united-states-fda-6247461)
- 2025-10-28 11:00 UTC [Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch](https://www.quantisnow.com/insight/nutriband-announces-successful-meeting-completed-with-united-states-fda-for-6246789)
- 2025-10-27 11:00 UTC [Nutriband Co-Founder Gareth Sheridan Returns as CEO](https://www.quantisnow.com/insight/nutriband-co-founder-gareth-sheridan-returns-as-ceo-6245188)
- 2025-10-21 17:50 UTC [SEC Form 5] [Goodman Gerald exercised 60,085 in-the-money shares at a strike of $1.93, increasing direct ownership by 1,001% to 66,085 units (SEC Form 5)](https://www.quantisnow.com/insight/goodman-gerald-exercised-60085-in-the-money-shares-at-a-strike-of-6239906)
- 2025-10-10 11:00 UTC [Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch](https://www.quantisnow.com/insight/nutriband-signs-agreement-with-brand-institute-to-develop-the-commercial-6229506)
- 2025-10-08 12:30 UTC [Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology](https://www.quantisnow.com/insight/nutriband-files-provisional-patent-application-for-enhanced-transdermal-abuse-deterrent-6227170)
- 2025-10-08 10:30 UTC [Conference Announcement] [Nutriband To Present at the Noble Capital Markets' Emerging Growth Virtual Equity Conference](https://www.quantisnow.com/insight/nutriband-to-present-at-the-noble-capital-markets-emerging-growth-6226911)
- 2025-09-24 20:05 UTC [Conference Announcement] [Nutriband Inc. to Present at the MicroCap Rodeo Conference](https://www.quantisnow.com/insight/nutriband-inc-to-present-at-the-microcap-rodeo-conference-6210509)
- 2025-09-10 13:15 UTC [Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl](https://www.quantisnow.com/insight/nutriband-inc-quarterly-report-highlights-record-revenue-for-q2-2025-6196130)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/NTRB
- Earnings history: https://www.quantisnow.com/earnings/NTRB
- Dividend history: https://www.quantisnow.com/dividends/NTRB
- Insider transactions: https://www.quantisnow.com/insiders/NTRB
- Options chain: https://www.quantisnow.com/options/NTRB
- SEC 8-K filings only: https://www.quantisnow.com/company/NTRB/8-k
- RSS and alerts for NTRB: https://www.quantisnow.com/docs/rss-feeds.md
